Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference

World News: . []

WARREN NJ May 13 2019 GLOBE NEWSWIRE -- Bellerophon Therapeutics Inc LINK  BLPH Bellerophon or the Company a clinical-stage biotherapeutics company today LINK  that it would present a late-breaking abstract with ad ditiona...

More news and information about Bellerophon Therapeutics, Inc.

Published By:

Globe Newswire: 13:30 GMT Monday 13th May 2019

Published: .

Search for other references to "bellerophon" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us